Related Experiment Videos
Serum retinol and prostate cancer
R B Hayes1, J F Bogdanovicz, F H Schroeder
1Department of Urology, Erasmus University, Rotterdam, the Netherlands.
Cancer
|November 1, 1988
Summary
Lower serum retinol levels are linked to increased prostate cancer risk. This study found significantly lower mean serum retinol in prostate cancer patients compared to controls, independent of confounding factors.
Area of Science:
- Nutritional biochemistry
- Oncology
- Epidemiology
Background:
- Prostate cancer is a significant health concern.
- Nutritional factors may influence cancer risk.
- Previous studies on carotenoids and tocopherols in prostate cancer have yielded mixed results.
Purpose of the Study:
- To investigate the association between serum levels of retinol, beta carotene, and alpha tocopherol and prostate cancer.
- To determine if these micronutrients are potential biomarkers for prostate cancer risk.
Main Methods:
- Serum samples were analyzed using high-performance liquid chromatography (HPLC).
- Levels of retinol, beta carotene, and alpha tocopherol were measured in patients with clinical prostate cancer, focal prostate cancer, benign prostatic hyperplasia, and hospital controls.
- Statistical analyses were performed to assess differences and trends.
Main Results:
- Serum retinol levels were significantly lower in prostate cancer patients compared to controls (P < 0.05).
- Beta carotene and alpha tocopherol levels varied with disease stage and treatment, complicating their association with risk.
- A statistically significant trend showed increased prostate cancer risk with decreasing serum retinol levels across quintiles (P < 0.05).
Conclusions:
- Serum retinol may be a potential biomarker for prostate cancer risk.
- Lower serum retinol levels are associated with an increased risk of developing prostate cancer.
- Further research is warranted to elucidate the role of retinol metabolism in prostate cancer pathogenesis.